[go: up one dir, main page]

DE69623087D1 - Brausemittel und dessen Herstellung - Google Patents

Brausemittel und dessen Herstellung

Info

Publication number
DE69623087D1
DE69623087D1 DE69623087T DE69623087T DE69623087D1 DE 69623087 D1 DE69623087 D1 DE 69623087D1 DE 69623087 T DE69623087 T DE 69623087T DE 69623087 T DE69623087 T DE 69623087T DE 69623087 D1 DE69623087 D1 DE 69623087D1
Authority
DE
Germany
Prior art keywords
active substance
physiologically active
effervescing
effervescent
core
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69623087T
Other languages
English (en)
Other versions
DE69623087T2 (de
Inventor
Toshihiro Shimizu
Tetsuro Tabata
Junichi Kikuta
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of DE69623087D1 publication Critical patent/DE69623087D1/de
Publication of DE69623087T2 publication Critical patent/DE69623087T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Detergent Compositions (AREA)
DE69623087T 1995-09-08 1996-09-06 Brausemittel und dessen Herstellung Expired - Lifetime DE69623087T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP25706495 1995-09-08

Publications (2)

Publication Number Publication Date
DE69623087D1 true DE69623087D1 (de) 2002-09-26
DE69623087T2 DE69623087T2 (de) 2003-04-24

Family

ID=17301247

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69623087T Expired - Lifetime DE69623087T2 (de) 1995-09-08 1996-09-06 Brausemittel und dessen Herstellung

Country Status (5)

Country Link
US (1) US5824339A (de)
EP (1) EP0761212B1 (de)
AT (1) ATE222487T1 (de)
CA (1) CA2184964A1 (de)
DE (1) DE69623087T2 (de)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE512835C2 (sv) * 1996-01-08 2000-05-22 Astrazeneca Ab Doseringsform innehållande en mångfald enheter alla inneslutande syralabil H+K+ATPas-hämmare
SE9600071D0 (sv) † 1996-01-08 1996-01-08 Astra Ab New oral formulation of two active ingredients I
US6365185B1 (en) * 1998-03-26 2002-04-02 University Of Cincinnati Self-destructing, controlled release peroral drug delivery system
KR100627614B1 (ko) * 1998-04-20 2006-09-25 에자이 가부시키가이샤 안정화된 벤즈이미다졸계 화합물 함유 조성물로 이루어지는 의약제제
CA2587022A1 (en) * 1998-05-18 1999-11-25 Takeda Pharmaceutical Company Limited Orally disintegrable tablets
SI1100469T1 (de) * 1998-07-28 2005-08-31 Takeda Pharmaceutical
SI1169024T1 (sl) * 1999-03-31 2006-06-30 Janssen Pharmaceutica Nv Predzelatinirani skrob v formulaciji s kontroliranim sproscanjem
GB9909801D0 (en) * 1999-04-28 1999-06-23 Btg Int Ltd Ultrasound detectable instrument
CA2378018A1 (en) * 1999-07-12 2001-01-18 Smithkline Beecham Corporation Heartburn treatment
US6264984B1 (en) 1999-12-06 2001-07-24 Bristol-Myers Squibb Company Effervescent histamine H2 antagonist composition
US6589555B2 (en) 1999-12-29 2003-07-08 Mahendra Pandya Effervescent vitaceutical compositions and related methods
AU2001236055A1 (en) * 2000-03-02 2001-09-12 Basf Aktiengesellschaft Coated granules and foaming compositions containing the same
WO2001091730A1 (en) 2000-05-31 2001-12-06 Drugtech Corporation Mineral supplement
AU2001296908A1 (en) * 2000-09-29 2002-04-08 Geneva Pharmaceuticals, Inc. Proton pump inhibitor formulation
US6558709B2 (en) 2001-01-05 2003-05-06 Howmedica Osteonics Corp. Calcium phosphate composition and method of preparing same
EP1391212A4 (de) * 2001-04-24 2008-09-03 Lintec Corp Orale darreichungsformen und träger für orale darreichungsformen
JP4993652B2 (ja) * 2004-03-31 2012-08-08 リンテック株式会社 経口投与剤
US8268333B2 (en) * 2001-04-24 2012-09-18 Lintec Corporation Orally administered agent and an orally administered agent/supporting substrate complex
EP1413294B1 (de) * 2001-07-27 2010-09-29 Astellas Pharma Inc. Zusammensetzung enthaltend feine Körner mit verzögerter Freisetzung für in der Mundhöhle schnell zerfallende Tabletten
US20040082618A1 (en) * 2002-07-03 2004-04-29 Rajneesh Taneja Liquid dosage forms of acid labile drugs
US20040005362A1 (en) * 2002-07-03 2004-01-08 Rajneesh Taneja Liquid dosage forms of acid labile drugs
PT1524967E (pt) * 2002-08-02 2008-04-03 Ratiopharm Gmbh Preparação farmacêutica contendo um composto de benzimidazole misturado com celulose microcristalina e método para a sua preparação.
US7048959B1 (en) 2003-01-09 2006-05-23 Kulisch Michael A Kinetic beverage for delivery of physiologically active substances
US20050220870A1 (en) * 2003-02-20 2005-10-06 Bonnie Hepburn Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
JP3881640B2 (ja) * 2003-08-08 2007-02-14 塩野義製薬株式会社 ロラタジンを含むドライシロップ剤
US20050249806A1 (en) * 2004-02-10 2005-11-10 Santarus, Inc. Combination of proton pump inhibitor, buffering agent, and nonsteroidal anti-inflammatory drug
JP2005298471A (ja) * 2004-03-17 2005-10-27 Lintec Corp 薬剤の製造方法
US7740883B2 (en) * 2004-03-28 2010-06-22 University Of Debrecen Nanoparticles from chitosan
US8282960B2 (en) * 2004-03-30 2012-10-09 Relypsa, Inc. Ion binding compositions
CA2557999C (en) * 2004-03-30 2013-11-12 Ilypsa, Inc. Methods and compositions for treatment of ion imbalances
US8192758B2 (en) * 2004-03-30 2012-06-05 Relypsa, Inc. Ion binding compositions
JP2005289867A (ja) * 2004-03-31 2005-10-20 Lintec Corp 経口投与剤
EP1742630A4 (de) * 2004-04-16 2010-01-20 Santarus Inc Kombination aus protonenpumpenhemmer, puffermittel und prokinetischem wirkstoff
US8815916B2 (en) 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
KR100627692B1 (ko) 2004-11-02 2006-09-25 (주)유라팜 Ａｃｅ 억제제 함유 제제의 제조방법 및 그 제제
US8308075B2 (en) 2005-04-19 2012-11-13 Kamterter Products, Llc Systems for the control and use of fluids and particles
US7311050B2 (en) * 2005-04-19 2007-12-25 Kamterter Ii, L.L.C. Systems for the control and use of fluids and particles
US7536962B2 (en) * 2005-04-19 2009-05-26 Kamterter Ii, L.L.C. Systems for the control and use of fluids and particles
DE112006002617T5 (de) * 2005-09-30 2008-08-28 Ilypsa Inc., Santa Clara Verfahren zur Herstellung von Core-Shell-Kompositen bzw. Kern-Hüllen-Kompositen mit vernetzten Hüllen und daraus entstehende Core-Shell-Komposite
CA2624170C (en) 2005-09-30 2014-02-25 Ilypsa, Inc. Methods and compositions for selectively removing potassium ion from the gastrointestinal tract of a mammal
AU2007266574A1 (en) * 2006-06-01 2007-12-06 Dexcel Pharma Technologies Ltd. Multiple unit pharmaceutical formulation
US20100168410A1 (en) * 2006-10-27 2010-07-01 Pfizer Products Inc. Hydroxypropyl Methyl Cellulose Hard Capsules and Process of Manufacture
AU2007317561A1 (en) 2006-10-27 2008-05-15 The Curators Of The University Of Missouri Compositions comprising at least one acid labile proton pump inhibiting agents, optionally other pharmaceutically active agents and methods of using same
US20080194307A1 (en) * 2007-02-13 2008-08-14 Jeff Sanger Sports-based game of chance
US20090053367A1 (en) * 2007-05-23 2009-02-26 Michael Kulisch Kinetic Beverage for Delivery of Physiologically Active Substances
CN101980700A (zh) 2008-02-20 2011-02-23 密苏里大学董事会 包含奥美拉唑和兰索拉唑以及缓冲剂的组合的组合物及其使用方法
DK2365988T4 (da) * 2008-08-22 2019-10-07 Vifor Int Ltd Tværbundne kationsbytningspolymerer, sammensætninger og anvendelse til behandling af hyperkaliæmi
ATE524979T1 (de) * 2008-09-30 2011-10-15 Hitschler Internat Gmbh & Co Kg Dragierte brausetabletten
CN101455196B (zh) * 2008-12-23 2012-09-05 中国人民解放军海军医学研究所 一种农药泡腾组合物及其制备方法
IT1395143B1 (it) * 2009-08-06 2012-09-05 Sofar Spa Composizioni granulari a rilascio controllato di mesalazina e processo per il loro ottenimento.
FR2949062B1 (fr) * 2009-08-12 2011-09-02 Debregeas Et Associes Pharma Nouvelles formulations pharmaceutiques contre le mesusage des medicaments
FR2949061B1 (fr) 2009-08-12 2013-04-19 Debregeas Et Associes Pharma Microgranules flottants
US8232238B2 (en) 2010-06-03 2012-07-31 The Clorox Company Concentrated film delivery systems
DE102010053748B4 (de) * 2010-12-08 2023-08-03 Jörg Schierholz Pharmazeutische Zusammensetzung zur Behandlung von Übergewicht
WO2016174664A1 (en) 2015-04-29 2016-11-03 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
US10617650B2 (en) 2015-10-16 2020-04-14 Merck Sharp & Dohme Corp. Process for preparing formulations for gastrointestinal-targeted therapies
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3131123A (en) * 1959-03-13 1964-04-28 Lab Francais De Therapeutique Enteric tablets and manufacture thereof
SE416649B (sv) * 1974-05-16 1981-01-26 Haessle Ab Forfarande for framstellning av foreningar som paverkar magsyrasekretionen
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
CA1193870A (en) * 1980-08-14 1985-09-24 Peter N. Tomlinson Abrasive product
US4472409A (en) * 1981-11-05 1984-09-18 Byk Gulden Lomberg Chemische Fabrik Gesellschaft Mit Beschrankter Haftung 2-Pyridylmethyl thio(sulfinyl)benzimidazoles with gastric acid secretion inhibiting effects
JPS6150978A (ja) * 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
CA1266235A (en) * 1985-03-25 1990-02-27 Wallace E. Becker Tablet composition for drug combinations
CA1327010C (en) * 1986-02-13 1994-02-15 Tadashi Makino Stabilized solid pharmaceutical composition containing antiulcer benzimidazole compound and its production
CA1276017C (en) * 1986-02-13 1990-11-06 Takeda Chemical Industries, Ltd. Sulfenamide derivatives and their production
GB2189698A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
GB2189699A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated acid-labile medicaments
FI90544C (fi) * 1986-11-13 1994-02-25 Eisai Co Ltd Menetelmä lääkeaineina käyttökelpoisten 2-pyridin-2-yyli-metyylitio- ja sulfinyyli-1H-bensimidatsolijohdannaisten valmistamiseksi
EP0452862B1 (de) * 1990-04-18 1995-07-19 Asahi Kasei Kogyo Kabushiki Kaisha Kugelförmige Keimkerne, kugelförmige Granulate sowie Verfahren zu deren Herstellung
US5312824A (en) * 1990-10-17 1994-05-17 Takeda Chemical Industries, Ltd. Certain 2-[(4-difluoromethoxy-2-pyridyl)-methylthio or methylsulfinyl-5-benzimidazoles useful for treating peptic ulcers
JP2820829B2 (ja) * 1991-03-07 1998-11-05 武田薬品工業株式会社 有核散剤およびその製造方法
DK0592484T3 (da) * 1991-07-01 1995-06-12 Gerhard Gergely Brusetablet
US5503846A (en) * 1993-03-17 1996-04-02 Cima Labs, Inc. Base coated acid particles and effervescent formulation incorporating same
ATE181672T1 (de) * 1993-04-28 1999-07-15 Takeda Chemical Industries Ltd Geschmacksmaskierte feste zubereitung und verfahren zur herstellung
TW280770B (de) * 1993-10-15 1996-07-11 Takeda Pharm Industry Co Ltd
DE69419492T2 (de) * 1994-03-01 2000-02-03 Gerhard Gergely Ein Brausesystem und einen Arzneiwirkstoff enthaltendes granuläres Produkt bzw. Tablette sowie Verfahren zu deren Herstellung
SE9500478D0 (sv) * 1995-02-09 1995-02-09 Astra Ab New pharmaceutical formulation and process

Also Published As

Publication number Publication date
DE69623087T2 (de) 2003-04-24
ATE222487T1 (de) 2002-09-15
EP0761212A2 (de) 1997-03-12
CA2184964A1 (en) 1997-03-09
US5824339A (en) 1998-10-20
EP0761212B1 (de) 2002-08-21
EP0761212A3 (de) 1997-11-12

Similar Documents

Publication Publication Date Title
DE69623087D1 (de) Brausemittel und dessen Herstellung
HUT50050A (en) Pharmaceutical compositions with controlled release of active ingredient and process for producing such compositions
EP1125577A3 (de) Flüssige Zusammensetzungen zur Arzneistoffabgabe
GEP20022707B (en) Biodegrading Macromers for the Controlled Release of Biologically Active Substances
AU6770490A (en) Solid pharmaceutical compositions containing cimetidine
ES2095818T1 (es) Composicion cosmetica y/o dermatologica de soporte hidrofilo y vitamina c mezclables extemporaneamente.
MX9704910A (es) Formula de liberacion controlada (albuterol).
HK1046244A1 (en) Controlled release and taste masking oral pharmaceutical compositions.
NO995313D0 (no) Mikroartikler nyttige som ultrasoniske kontrastmidler og til levering av legemidler i blodbanen
CA2416383A1 (en) Solution-, dispersion- or emulsion-producing film dermatics
CA2119253A1 (en) Medication Vehicles Made of Solid Lipid Particles (Solid Lipid Nanospheres-SLN)
FR2774288B1 (fr) Microgranules d'omeprazole gastroproteges, procede d'obtention et preparations pharmaceutiques
HUT53813A (en) Coating material controlling release of medicaments
AU4302100A (en) Ketoprofen microgranules, method for preparing same and pharmaceutical compositions
CA2000932A1 (en) Oral pharmaceutical controlled release multiple unit dosage form
GEP20022629B (en) Sustained-Release Microgranules Containing Diltiazem As The Active Principle and Gelatinous Capsule Containing the Same
AU668767B2 (en) Oral medicament form
PL317996A1 (en) Carbamazepinic form of a drug with retarded release of biologically active substance
GB9815801D0 (en) Liquid polymeric compositions for controlled released bioactive substances
GB2323532B (en) Process for the preparation of a stable fixed dose pharmaceutical composition of anti-infective agent(s) and micro organisms as active ingredients

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: TAKEDA PHARMACEUTICAL CO. LTD., OSAKA, JP